BAP1在超过70%的恶性腹膜间皮瘤中通过拷贝数丢失、突变和/或蛋白表达缺失发生改变
研究收集46例腹膜间皮瘤患者的生物学材料及临床流行病学数据,评估BAP1突变和蛋白表达状态并结合既往拷贝数改变数据。结果显示32%存在BAP1突变,42%存在拷贝数丢失,73%携带至少一个失活BAP1等位基因,仅57%完全缺失核蛋白表达;BAP1突变、蛋白表达缺失或任一改变与更好的总生存相关,且独立于组织学亚型、年龄和性别。BAP1核蛋白表达是比突变或拷贝数丢失更可靠的BAP1活性完全缺失标志物和良好预后因素。
要点
- 73%的恶性腹膜间皮瘤携带至少一个失活BAP1等位基因。
- BAP1突变见于32%,拷贝数丢失见于42%,核蛋白完全缺失仅57%。
- BAP1突变(p=0.04)、蛋白表达缺失(p=0.016)或任一改变(p=0.007)与更好总生存相关。
核心结论
- 与胸膜间皮瘤一样,BAP1失活在腹膜间皮瘤中常见;BAP1核蛋白表达是良好预后因素,且是比突变或拷贝数丢失更可靠的BAP1活性完全缺失标志物。
研究设计与样本
- 依托法国国家恶性胸膜间皮瘤与罕见腹膜肿瘤诊断网络及法国国家罕见腹膜表面恶性肿瘤治疗网络,收集46例腹膜间皮瘤患者的生物学材料及临床和流行病学数据。
- 评估BAP1突变和蛋白表达水平,并结合既往对同一样本拷贝数改变的数据进行分析。
主要发现
- 在分析的恶性腹膜间皮瘤中,32%检出BAP1突变。
- 既往报告该系列样本中42%发生拷贝数丢失。
- 总体上,73%的恶性腹膜间皮瘤携带至少一个失活BAP1等位基因,但仅57%完全缺失BAP1核蛋白表达。
- BAP1突变患者的总生存更好(p=0.04),蛋白表达缺失患者的总生存更好(p=0.016),携带至少一种上述改变患者的总生存更好(p=0.007),且独立于肿瘤组织学亚型、年龄和性别。
临床怎么用
- 作者认为BAP1核蛋白表达是良好预后因素,且是比突变或拷贝数丢失更可靠的BAP1活性完全缺失标志物。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Malignant mesothelioma is a deadly disease that is strongly associated with asbestos exposure. Peritoneal mesotheliomas account for 10% of all the cases. BRCA1 associated protein 1 (BAP1) is a deubiquitinating hydrolase that plays a key role in various cellular processes. Germline and somatic inactivation of BRCA1 associated protein 1 gene (BAP1) is frequent in pleural mesothelioma; however, little is known about its status in peritoneal mesothelioma. METHODS: Taking advantage of the extensive French National Network for the Diagnosis of Malignant Pleural Mesothelioma and Rare Peritoneal Tumors and the French National Network for the Treatment of Rare Peritoneal Surface Malignancies, we collected biological material and clinical and epidemiological data for 46 patients with peritoneal mesothelioma. The status of BAP1 was evaluated at the mutational and protein expression levels and combined with our previous data on copy number alterations assessed in the same samples. RESULTS: We detected mutations in 32% of the malignant peritoneal mesotheliomas analyzed. In addition, we have previously reported that copy number losses occurred in 42% of the samples included in this series. Overall, 73% of the malignant peritoneal mesotheliomas analyzed carried at least one inactivated BAP1 allele, but only 57% had a complete loss of its protein nuclear expression. Better overall survival was observed for patients with BAP1 mutations (p = 0.04), protein expression loss (p = 0.016), or at least one of these alterations (p = 0.007) independently of tumor histological subtype, age, and sex. CONCLUSIONS: As in pleural mesothelioma, inactivation of BAP1 is frequent in peritoneal mesotheliomas. We found that BAP1 protein nuclear expression is a good prognostic factor and a more reliable marker for the complete loss of BAP1 activity than mutation or copy number loss.
引用
- Leblay N, Leprêtre F, Le Stang N, et al. BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas. J Thorac Oncol. 2016. PMID: 28034829. doi:10.1016/j.jtho.2016.12.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。